Idaho Attorney General Lawrence Wasden announced on Oct. 17 a settlement with 40 other states and D.C. requiring Johnson & Johnson and its subsidiary Ethicon, Inc. to pay nearly $116.9 million for deceptive marketing of transvaginal surgical mesh devices.

     According to a press release from the Attorney General’s Office, Johnson & Johnson falsely advertised that the mesh was FDA approved, failed to properly represent risks associated with the procedure and wrongly represented that risks would be eliminated with surgical experience and technique alone.

     The transvaginal surgical mesh is a synthetic material used to support the pelvic organs of women who suffer from stress urinary incontinence and pelvic organ prolapse.

     Idaho’s portion of the settlement will be deposited into Idaho’s Consumer Protection Fund, according to the press release.

Load comments